Online citations, reference lists, and bibliographies.
← Back to Search

Incidence And Economic Burden Of Osteoporosis‐Related Fractures In The United States, 2005–2025

R. Burge, B. Dawson-Hughes, D. Solomon, J. Wong, A. King, A. Tosteson
Published 2007 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This study predicts the burden of incident osteoporosis‐related fractures and costs in the United States, by sex, age group, race/ethnicity, and fracture type, from 2005 to 2025. Total fractures were >2 million, costing nearly $17 billion in 2005. Men account for >25% of the burden. Rapid growth in the disease burden is projected among nonwhite populations.
This paper references
Hip, pelvis Probability of remaining in NH (7%) × 365 days × $164/day
(1994)
Healthcare Cost and Utilization Project
(2001)
10.1359/jbmr.1997.12.1.24
Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis Foundation
N. F. Ray (1997)
Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
J. G. Brecht (2003)
10.1046/j.1532-5415.2003.51110.x
Estimating Hip Fracture Morbidity, Mortality and Costs
R. Braithwaite (2003)
% discharged to home × % admitted from home to NH facility (9%) × 91 days (median stay) × $164/day [H] Proportion who stay full 6 months (assume 0%) × 182 days × $164/day
10.1056/NEJM200105103441904
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
R. Neer (2001)
Other includes clavicle, humerus (shaft/distal, proximal), leg (shaft/ distal femur, patella, tibia/fibia), and hands/fingers. APPENDIX 4
10.1016/S0002-9343(05)80037-3
The economic and human costs of osteoporotic fracture.
E. Barrett-connor (1995)
MetLife Market Survey of Nursing Home & Home Care Costs
Grabowski (2002)
The direct medical costs of osteoporosis for American women aged 45 and older
S Phillips (1988)
10.1089/JWH.1.1999.8.1077
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.
T. Hoerger (1999)
10.1007/s00198-005-1869-5
Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
A. King (2005)
10.1007/s001980050010
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
J. Reginster (2000)
Long-term care costs-subsequent years 2-5
10.1007/s001980050113
Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time
L. Melton Iii (1999)
10.1016/8756-3282(94)90813-3
Costs and health effects of osteoporotic fractures.
E. Chrischilles (1994)
United States life tables
E. Arias (2004)
10.1001/ARCHPEDI.159.8.759
Individual and neighborhood-level factors in predicting asthma.
Chandan K. Saha (2005)
10.1210/JCEM.85.11.6953
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.
D. Black (2000)
Frequency of Occurence, Impact and Cost of Selected Musculoskeletal Conditions in the United States. Chicago, IL: American Academy of Orthopedic Surgeons
TL Holbrook (1984)
10.1016/S0149-2918(04)90002-1
Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment.
W. Olszynski (2004)
Vertebral Unit cost values per year for years 2-5 are equal to values for first year Assumption Wrist, other Costs not captured
Proportion remaining in NH during second six months (89% of patients with full stay during second 6-month period) × 182 days × $164/day Pathway: discharged from hospital to own home
Hip Fracture Outcomes in People Age 50 and Over-Background Paper
U S Congress (1994)
Department of Health and Human Services, Office of the Surgeon General. 22. Osteoporosis 1998 Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis
(2004)
Musculoskeletal Conditions in the United States
Allan Praemer (1992)
10.1007/s001980170036
Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions
A. Tosteson (2001)
10.1046/J.1524-4733.2003.65261.X
Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025.
R. Burge (2003)
U . S . Census Bureau 2004 U . S . interim projections by age , sex , race , and Hispanic origin 2000 - 2050
CM Klotzbuecher (2000)
Population Projections of the United States by Age, Sex, Race, and Hispanic Origin
J C Day (1995)
interim projections by age, sex, race, and Hispanic origin 2000-2050
10.1007/PL00004168
Osteoporosis in Men
E. Seeman (1999)
10.1377/HLTHAFF.W4.363
Recent trends in state nursing home payment policies.
D. Grabowski (2004)
Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050
JC Day (1996)
United States Life Tables, 2001.
E. Arias (2004)
10.1186/1471-2261-5-16
Determinants of racial/ethnic differences in blood pressure management among hypertensive patients
L. Hicks (2005)
Congress Office of Technical Assistance 1994 Hip fracture outcomes in people age fifty and over
Strontium ranelate reduces the risk of nonvertebral fractures in post-menopausal women with osteoporosis: Tropos Study
JY Reginster (2005)
10.2105/AJPH.2004.044222
Racial/ethnic disparities in potentially preventable readmissions: the case of diabetes.
H. Jiang (2005)
10.1210/JC.2004-1774
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
J. Reginster (2005)
10.1001/JAMA.282.14.1344
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
S. Harris (1999)
Proportion who stay full 6 months (assume 0%) × 182 days × $164/day
Comparable fracture incidence rate tables for Hispanic, black, and Other are available on request. * Calculated from NIS
Melton (1999)
proportion staying full second 6 months in SNF (89%); percent admitted from a rehab facility to a NH (SNF or ICF) (7%)
Short-Term Cost-Effectiveness of Bisphosphonate Therapies for Postmenopausal Osteoporotic Women at High Risk of Fracture
D. Grima (2003)
10.1111/j.1524-6175.2005.04103.x
Ethnicity and Blood Pressure
S. Oparil (2005)
10.1359/jbmr.2000.15.4.721
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
C. M. Klotzbuecher (2000)
10.1016/8756-3282(88)90009-9
The direct medical costs of osteoporosis for American women aged 45 and older, 1986.
S. Phillips (1988)
other National ratio of NH/inpatient costs multiplied by inpatient cost estimate, by age, sex, race/ethnicity, for each geographic area, updated to 2005 National nursing home/inpatient cost ratio
Wrist Vertebral
National Osteoporosis Foundation 2002 America's Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation
10.1097/00006254-200105000-00022
Fracture Risk Reduction With Alendronate in Women With Osteoporosis: The Fracture Intervention Trial
D. Black (2001)



This paper is referenced by
10.1053/J.OTO.2011.06.001
Current Concepts in the Management of Vertebral Compression Fractures
S. Mukherjee (2011)
10.31486/toj.19.0084
Superior Gluteal Artery Bleed After Cephalomedullary Nail Fixation
C. Carroll (2020)
10.1016/j.otsr.2010.04.012
Hospitalized wrist fractures in France: Incidence and burden trend changes.
M. Maravic (2010)
10.12674/ptk.2020.27.2.155
Effect on the Limit of Stability of the Lowered Center of Mass With a Weight Belt
Jimmy Phan (2020)
10.1302/2058-5241.4.180062
Pelvic ring fractures in the elderly
M. Küper (2019)
10.1002/jbmr.1695
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
B. Langdahl (2012)
10.1002/jor.21086
Inhibition of STAT1 accelerates bone fracture healing
K. Tajima (2010)
10.1186/s40697-016-0118-5
Conventional hemodialysis is associated with greater bone loss than nocturnal hemodialysis: a retrospective observational study of a convenience cohort
B. L. Auguste (2016)
10.7326/0003-4819-155-11-201112060-00007
Cost-Effectiveness of Different Screening Strategies for Osteoporosis in Postmenopausal Women
Smita Nayak (2011)
10.22603/ssrr.2019-0079
The Surgical Outcomes of Spinal Fusion for Osteoporotic Vertebral Fractures in the Lower Lumbar Spine with a Neurological Deficit
Norihiro Isogai (2020)
Do In-Line Dance, Progressively Loaded Squats and Foot Stomping Affect the Parameters of Fracture Risk in Postmenopausal Women?
C. Young (2007)
10.1503/cmaj.070981
Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial
S. Majumdar (2008)
10.1007/S11914-008-0004-X
Intravenous zoledronic acid for the treatment of osteoporosis
E. Lewiecki (2008)
10.1517/17425255.4.7.941
Ibandronate in profile: drug characteristics and clinical efficacy
J. Reginster (2008)
10.1093/AJCN/88.2.537S
Serum 25-hydroxyvitamin D and functional outcomes in the elderly.
B. Dawson-Hughes (2008)
10.1038/ki.2008.264
Chronic kidney disease and bone fracture: a growing concern.
T. Nickolas (2008)
10.1007/s11606-009-0936-6
Factors Associated with Osteoporosis Screening and Recommendations for Osteoporosis Screening in Older Adults
S. Nayak (2009)
10.1016/S0716-8640(10)70603-9
Estrategias de prevención en la salud de la mujer
P. M. Bianchi (2010)
10.1210/er.2009-0044
Genetics of osteoporosis.
S. Ralston (2010)
10.3233/THC-2011-0643
Quality of nutrition related information on the internet for osteoporosis patients: a critical review.
M. P. Joshi (2011)
10.2174/157488709788186030
Evaluating the antifracture efficacy of bisphosphonates.
M. Pazianas (2009)
10.1016/j.tem.2009.05.003
Depression as a risk factor for osteoporosis
G. Cizza (2009)
10.1200/JCO.2011.38.7001
Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
K. Ito (2012)
Denosumab: recent update in postmenopausal osteoporosis.
I. Silva (2012)
10.1093/gerona/glt093
Public health impact of osteoporosis.
J. Cauley (2013)
10.1016/j.phrs.2011.03.012
Green tea and bone health: Evidence from laboratory studies.
Chwan-Li Shen (2011)
10.1017/S1462399411001980
Insights into the genetics of osteoporosis from recent genome-wide association studies.
H. Zheng (2011)
Original article Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women
Alexandra G. Ellis (2014)
10.1177/2151458514528951
Preoperative Factors and Early Complications Associated With Hemiarthroplasty and Total Hip Arthroplasty for Displaced Femoral Neck Fractures
Christopher P Miller (2014)
10.1039/C3SM50798J
The multi-faceted role of the actin cap in cellular mechanosensation and mechanotransduction.
Dong-Hwee Kim (2013)
10.1016/B978-0-323-18907-1.00069-X
Chapter 69 – Osteoporosis
Roland D. Chapurlat (2016)
10.1055/s-0035-1556582
Ovariectomy-Induced Osteoporosis Does Not Impact Fusion Rates in a Recombinant Human Bone Morphogenetic Protein-2–Dependent Rat Posterolateral Arthrodesis Model
J. Ghodasra (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar